ACE2 and COVID-19: A study by Xu et al.22 revealed that angiotensin converting enzyme 2 (ACE2), a receptor for SARS-CoV2, is highly expressed in the epithelial cells of the oral mucosa and in the tongue, suggesting the rationale behind the high viral load content of saliva in COVID-19 patients.